Inhibition of ceramide de novo synthesis with myriocin affects lipid metabolism in the liver of rats with streptozotocin-induced type 1 diabetes

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Kurek, Krzysztof ^a   Wiesiołek Kurek, Patrycja ^a   Piotrowska, Dominika M ^a   Łukaszuk, Bartłomiej ^a   Chabowski, Adrian ^a   Zendzian Piotrowska, Małgorzata ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE CERAMIDASE; CERAMIDE; DIACYLGLYCEROL; FATTY ACID; GLUCOSE; GLYCOGEN; INSULIN; PROTEIN KINASE B; SPHINGANINE; SPHINGOLIPID; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE 1 PHOSPHATE; STREPTOZOCIN; THERMOZYMOCIDIN; IMMUNOSUPPRESSIVE AGENT; MONOUNSATURATED FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLYCOGEN LIVER LEVEL; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; LIPID LIVER LEVEL; LIPID METABOLISM; LIPOGENESIS; LIVER METABOLISM; MALE; METABOLIC INHIBITION; NONHUMAN; PROTEIN EXPRESSION; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TREATMENT DURATION; WEIGHT REDUCTION; ANIMAL; BIOSYNTHESIS; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; LIVER; METABOLISM; PATHOLOGY; WISTAR RAT;

ANIMALS; CERAMIDES; DIABETES MELLITUS, EXPERIMENTAL; FATTY ACIDS, MONOUNSATURATED; IMMUNOSUPPRESSIVE AGENTS; LIPID METABOLISM; LIVER; MALE; RATS; RATS, WISTAR;

EID: 84896260705     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/980815     Document Type: Article

References (41)

1. Wild S., Roglic G., Green A., Sicree R., King H., Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004 27 5 1047 1053 2-s2.0-2342466734 10.2337/diacare.27.5.1047 (Pubitemid 38579764)
2. Hannun Y. A., Obeid L. M., Principles of bioactive lipid signalling: lessons from sphingolipids. Nature Reviews Molecular Cell Biology 2008 9 2 139 150 2-s2.0-38549152194 10.1038/nrm2329 (Pubitemid 351158911)
3. Kurek K., Lukaszuk B., Piotrowska D. M., Wiesiołek P., Chabowska A. M., Zendzian-Piotrowska M., Metabolism, physiological role and clinical implications of sphingolipids in gastrointestinal tract. BioMed Research International 2013 2013 10 908907 10.1155/2013/908907
4. Holland W. L., Summers S. A., Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism. Endocrine Reviews 2008 29 4 381 402 2-s2.0-45149106053 10.1210/er.2007-0025 (Pubitemid 351831506)
5. Holland W. L., Knotts T. A., Chavez J. A., Wang L., Hoehn K. L., Summers S. A., Lipid mediators of insulin resistance. Nutrition Reviews 2007 65 6, part 2 S39 4S6 2-s2.0-34547409960
6. Stratford S., DeWald D. B., Summers S. A., Ceramide dissociates 3′-phosphoinositide production from pleckstrin homology domain translocation. Biochemical Journal 2001 354 part 2 359 368 2-s2.0-0035281991 10.1042/0264-6021:3540359 (Pubitemid 32209874)
7. Salinas M., López-Valdaliso R., Martín D., Alvarez A., Cuadrado A., Inhibition of PKB/Akt1 by C2-ceramide involves activation of ceramide-activated protein phosphatase in PC12 cells. Molecular and Cellular Neurosciences 2000 15 2 156 169 2-s2.0-0342980927 10.1006/mcne.1999.0813 (Pubitemid 30109119)
8. Zinda M. J., Vlahos C. J., Lai M. T., Ceramide induces the dephosphorylation and inhibition of constitutively activated Akt in PTEN negative U87MG cells. Biochemical and Biophysical Research Communications 2001 280 4 1107 1115 2-s2.0-0034816711 10.1006/bbrc.2000.4248 (Pubitemid 32924454)
9. Summers S. A., Ceramides in insulin resistance and lipotoxicity. Progress in Lipid Research 2006 45 1 42 72 2-s2.0-31644443192 10.1016/j.plipres.2005.11. 002 (Pubitemid 43170804)
10. Kelpe C. L., Moore P. C., Parazzoli S. D., Wicksteed B., Rhodes C. J., Poitout V., Palmitate inhibition of insulin gene expression is mediated at the transcriptional level via ceramide synthesis. The Journal of Biological Chemistry 2003 278 32 30015 30021 2-s2.0-0042531617 10.1074/jbc.M302548200 (Pubitemid 36962391)
11. Maedler K., Oberholzer J., Bucher P., Spinas G. A., Donath M. Y., Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic β -cell turnover and function. Diabetes 2003 52 3 726 733 2-s2.0-0345354674 10.2337/diabetes.52.3.726 (Pubitemid 36323580)
12. Sjoholm A., Ceramide inhibits pancreatic β -cell insulin production and mitogenesis and mimics the actions of interleukin-1 β FEBS Letters 1995 367 3 283 286 2-s2.0-0029059122 10.1016/0014-5793(95)00470-T
13. Laychock S. G., Tian Y., Sessanna S. M., Endothelial differentiation gene receptors in pancreatic islets and INS-1 cells. Diabetes 2003 52 8 1986 1993 2-s2.0-0042266314 10.2337/diabetes.52.8.1986 (Pubitemid 36919790)
14. Laychock S. G., Sessanna S. M., Lin M., Mastrandrea L. D., Sphingosine 1-phosphate affects cytokine-induced apoptosis in rat pancreatic islet β -cells. Endocrinology 2006 147 10 4705 4712 2-s2.0-33748754785 10.1210/en.2006-0456 (Pubitemid 44402178)
15. Bonen A., Tandon N. N., Glatz J. F. C., Luiken J. J. F. P., Heigenhauser G. J. F., The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes. International Journal of Obesity 2006 30 6 877 883 2-s2.0-33744454918 10.1038/sj.ijo.0803212 (Pubitemid 43801185)
16. Reynoso R., Salgado L. M., Calderón V., High levels of palmitic acid lead to insulin resistance due to changes in the level of phosphorylation of the insulin receptor and insulin receptor substrate-1. Molecular and Cellular Biochemistry 2003 246 1-2 155 162 2-s2.0-0038755467 10.1023/A:1023423005187 (Pubitemid 36798736)
17. Petersen K. F., Dufour S., Savage D. B., Bilz S., Solomon G., Yonemitsu S., Cline G. W., Befroy D., Zemany L., Kahn B. B., Papademetris X., Rothman D. L., Shulman G. I., The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proceedings of the National Academy of Sciences of the United States of America 2007 104 31 12587 12594 2-s2.0-34547911800 10.1073/pnas.0705408104 (Pubitemid 47255198)
18. Petersen K. F., Befroy D., Dufour S., Dziura J., Ariyan C., Rothman D. L., DiPietro L., Cline G. W., Shulman G. I., Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 2003 300 5622 1140 1142 2-s2.0-0038025371 10.1126/science.1082889 (Pubitemid 36583097)
19. Fujita T., Inoue K., Yamamoto S., Ikumoto T., Sasaki S., Toyama R., Chiba K., Hoshino Y., Okumoto T., Fungal metabolites. A potent immunosuppressive activity found in Isaria sinclairii metabolite. Journal of Antibiotics 1994 47 2 208 215 2-s2.0-0028372227
20. Hanada K., Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism. Biochimica et Biophysica Acta 2003 1632 1-3 16 30 2-s2.0-0037680229 10.1016/S1388-1981(03)00059-3 (Pubitemid 36628112)
21. Hojjati M. R., Li Z., Zhou H., Tang S., Huan C., Ooi E., Lu S., Jiang X., Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice. The Journal of Biological Chemistry 2005 280 11 10284 10289 2-s2.0-15444367538 10.1074/jbc.M412348200 (Pubitemid 40395884)
22. Park T., Rosebury W., Kindt E. K., Kowala M. C., Panek R. L., Serine palmitoyltransferase inhibitor myriocin induces the regression of atherosclerotic plaques in hyperlipidemic ApoE-deficient mice. Pharmacological Research 2008 58 1 45 51 2-s2.0-50649104363 10.1016/j.phrs.2008.06.005
23. Holland W. L., Brozinick J. T., Wang L., Hawkins E. D., Sargent K. M., Liu Y., Narra K., Hoehn K. L., Knotts T. A., Siesky A., Nelson D. H., Karathanasis S. K., Fontenot G., Birnbaum M. J., Summers S. A., Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metabolism 2007 5 3 167 179 2-s2.0-33847332202 10.1016/j.cmet.2007.01.002
24. Kurek K., Piotrowska D. M., Wiesiołek-Kurek P., Lukaszuk B., Chabowski A., Górski J., Zendzian-Piotrowska M., Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease. Liver International 2013 10.1111/liv.12331
25. Bligh E. G., Dyer W. J., A rapid method of total lipid extraction and purification. Canadian Journal of Biochemistry and Physiology 1959 37 8 911 917 2-s2.0-33845261493
26. Min J., Yoo H., Lee E., Lee W., Lee Y., Simultaneous quantitative analysis of sphingoid base 1-phosphates in biological samples by o-phthalaldehyde precolumn derivatization after dephosphorylation with alkaline phosphatase. Analytical Biochemistry 2002 303 2 167 175 2-s2.0-0037089472 10.1006/abio.2002.5579 (Pubitemid 34407580)
27. Liu B., Hannun Y. A., Sphingomyelinase assay using radiolabeled substrate. Methods in Enzymology 1999 311 164 167 2-s2.0-0032742602 10.1016/S0076-6879(00)11077-8 (Pubitemid 29512761)
28. Nikolova-Karakashian M., Merrill A. H. Jr., Ceramidases. Methods in Enzymology 1999 311 194 201 2-s2.0-0032738766 10.1016/S0076-6879(00)11081-X (Pubitemid 29512765)
29. Kepler D., Decker K., Glycogen: determination with amyloglucosidase. Methods of Enzymatic Analysis 1974 Academic Press 1126 1131
30. Miklosz A., Chabowski A., Zendzian-Piotrowska M., Gorski J., Effects of hyperthyroidism on lipid content and composition in oxidative and glycolytic muscles in rats. Journal of Physiology and Pharmacology 2012 63 403 410
31. Sakata N., Yoshimatsu G., Tsuchiya H., Egawa S., Unno M., Animal models of diabetes mellitus for islet transplantation. Experimental Diabetes Research 2012 2012 11 256707 10.1155/2012/256707
32. Car H., Zendzian-Piotrowska M., Prokopiuk S., Fiedorowicz A., Sadowska A., Kurek K., Sawicka D., Ceramide profiles in the brain of rats with diabetes induced by streptozotocin. FEBS Journal 2012 279 11 1943 1952 2-s2.0-84859723669 10.1111/j.1742-4658.2012.08575.x
33. Yang G., Badeanlou L., Bielawski J., Roberts A. J., Hannun Y. A., Samad F., Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome. American Journal of Physiology- Endocrinology and Metabolism 2009 297 1 E211 E224 2-s2.0-67650096801 10.1152/ajpendo.91014.2008
34. Ussher J. R., Koves T. R., Cadete V. J. J., Zhang L., Jaswal J. S., Swyrd S. J., Lopaschuk D. G., Proctor S. D., Keung W., Muoio D. M., Lopaschuk G. D., Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption. Diabetes 2010 59 10 2453 2464 2-s2.0-77956022194 10.2337/db09-1293
35. Trauner M., Arrese M., Wagner M., Fatty liver and lipotoxicity. Biochimica et Biophysica Acta 2010 1801 3 299 310 2-s2.0-76049103016 10.1016/j.bbalip.2009.10.007
36. Ferrannini E., Lanfranchi A., Rohner-Jeanrenaud F., Manfredini G., Van de Werve G., Influence of long-term diabetes on liver glycogen metabolism in the rat. Metabolism 1990 39 10 1082 1088 2-s2.0-0025147319 10.1016/0026-0495(90) 90170-H (Pubitemid 20351268)
37. de Oliveira D. S., Amado C. A. B., Martini M. C., Suzuki-Kemmelmeier F., Bracht A., Glycogen levels and energy status of the liver of fasting rats with diabetes types 1 and 2. Brazilian Archives of Biology and Technology 2007 50 5 785 791 2-s2.0-37749050475
38. van Sluijters D. A., van Woerkom G. M., Aerts J. M. F. G., Meijer A. J., Sphingomyelinase treatment of rat hepatocytes inhibits cell-swelling-stimulated glycogen synthesis by causing cell shrinkage. European Journal of Biochemistry 1999 266 2 653 659 2-s2.0-0033485412 10.1046/j.1432-1327.1999.00914.x
39. Bachnio-Zabielska A., Zabielski P., Baranowski M., Gorski J., Effects of streptozotocin-induced diabetes and elevation of plasma FFA on ceramide metabolism in rat skeletal muscle. Hormone and Metabolic Research 2010 42 1 1 7 2-s2.0-73949140458 10.1055/s-0029-1238322
40. Resjö S., Göransson O., Härndahl L., Zolnierowicz S., Manganiello V., Degerman E., Protein phosphatase 2A is the main phosphatase involved in the regulation of protein kinase B in rat adipocytes. Cellular Signalling 2002 14 3 231 238 2-s2.0-0036154215 10.1016/S0898-6568(01)00238-8 (Pubitemid 34102452)
41. Dekker M. J., Baker C., Naples M., Samsoondar J., Zhang R., Qiu W., Sacco J., Adeli K., Inhibition of sphingolipid synthesis improves dyslipidemia in the diet-induced hamster model of insulin resistance: evidence for the role of sphingosine and sphinganine in hepatic VLDL-apoB100 overproduction. Atherosclerosis 2013 228 1 98 109